Bionexus gene lab corp. signs strategic partnership mou with shenzhen rongguang group to advance cancer screening, precision medicine, and preventative healthcare solutions

Kuala lumpur, malaysia, sept. 13, 2024 (globe newswire) -- bionexus gene lab corp. (nasdaq: bglc, the “company”), an emerging biotechnology company focused on innovative healthcare solutions, is pleased to announce the signing of a strategic partnership memorandum of understanding (mou) with shenzhen rongguang health group, a major healthcare services provider in china. this partnership aims to expand the company's expertise and presence in cancer screening, precision medicine, and preventative healthcare through its subsidiary mrna scientific sdn bhd.
BGLC Ratings Summary
BGLC Quant Ranking